Literature DB >> 8555414

Glutathione conjugation of the cytostatic drug ifosfamide and the role of human glutathione S-transferases.

H A Dirven1, L Megens, M J Oudshoorn, M A Dingemanse, B van Ommen, P J van Bladeren.   

Abstract

Development of drug resistance against alkylating cytostatic drugs has been associated with higher intracellular concentrations of glutathione (GSH) and increased expression of glutathione S-transferase (GST) enzymes. Therefore, enhanced detoxification by the glutathione/glutathione S-transferase pathway has been proposed as a major factor in the development of drug resistance toward alkylating agents. In this paper we describe 31P NMR and HPLC studies on the spontaneous and glutathione S-transferase catalyzed formation of glutathionyl conjugates of two metabolites of ifosfamide, i.e., 4-hydroxyifosfamide and ifosfamide mustard. At 25 degrees C activated ifosfamide (= 4-hydroxyifosfamide + aldoifosfamide) disappeared faster in the presence of a 10-fold excess of GSH (t1/2 = 107 min) compared to incubations without GSH (t1/2 = 266 min). No evidence for the formation of 4-glutathionyl ifosfamide was found. The ultimate alkylating species of ifosfamide is ifosfamide mustard (IM). In the absence of glutathione, the rate constant for the disappearance of the ifosfamide mustard signal at 25 degrees C (pH 7) was 1.98 x 10(-3) min-1 (t1/2 = 350 min). In the presence of a 10-fold molar excess of glutathione, this rate constant was 1.95 x 10(-3) min-1 (t1/2 = 355 min), indicating that the spontaneous formation of an aziridinium ion is the rate-limiting event in the reaction with glutathione. The aziridinium ion formed from IM can deprotonate upon formation, leading to the formation of a (noncharged) aziridine species. This intermediate (N-(2-chloroethyl)-N'-phosphoric acid diamide) was characterized by 31P, 1H, and 13C NMR spectra. When 2 mM ifosfamide mustard was incubated with 1 mM GSH in the presence of 40 microM GST P1-1, the formation of monoglutathionyl ifosfamide mustard was 2.3-fold increased above the spontaneous level. The other major human isoenzymes tested (A1-1, A2-2, and M1a-1a) did not influence the formation of monoglutathionyl ifosfamide mustard. The results of these studies demonstrate that increased levels of GST P1-1 can contribute to an enhanced detoxification of ifosfamide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8555414     DOI: 10.1021/tx00049a012

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  11 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics.

Authors:  Daniella Lowenberg; Caroline F Thorn; Zeruesenay Desta; David A Flockhart; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-02       Impact factor: 2.089

3.  Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.

Authors:  J M Allan; C P Wild; S Rollinson; E V Willett; A V Moorman; G J Dovey; P L Roddam; E Roman; R A Cartwright; G J Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

4.  Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.

Authors:  Fei Li; Andrew D Patterson; Constance C Höfer; Kristopher W Krausz; Frank J Gonzalez; Jeffrey R Idle
Journal:  Biochem Pharmacol       Date:  2010-06-10       Impact factor: 5.858

5.  Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus.

Authors:  Shilong Zhong; Min Huang; Xiuyan Yang; Liuqin Liang; Yixi Wang; Marjorie Romkes; Wei Duan; Eli Chan; Shu-Feng Zhou
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

6.  Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor.

Authors:  Masahiro Nomoto; Masaaki Miyata; Shanai Yin; Yasushi Kurata; Miki Shimada; Kouichi Yoshinari; Frank J Gonzalez; Kokichi Suzuki; Shigeki Shibasaki; Tohru Kurosawa; Yasushi Yamazoe
Journal:  Biol Pharm Bull       Date:  2009-02       Impact factor: 2.233

7.  N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats.

Authors:  N Chen; K Aleksa; C Woodland; M Rieder; G Koren
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

Review 8.  Glutathione analogues in cancer treatment.

Authors:  David Hamilton; Gerald Batist
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

9.  Glutathione, glutathione-dependent enzymes and antioxidant status in erythrocytes from children treated with high-dose paracetamol.

Authors:  Eran Kozer; Sandra Evans; Joseph Barr; Revital Greenberg; Ingrid Soriano; Mordechai Bulkowstein; Irena Petrov; Zehava Chen-Levi; Bernard Barzilay; Matitiahu Berkovitch
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

10.  Investigation of Ifosfamide Toxicity Induces Common Upstream Regulator in Liver and Kidney.

Authors:  Hyoung-Yun Han; Mi-Sun Choi; Seokjoo Yoon; Je-Won Ko; Sang-Kyum Kim; Tae-Won Kim
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.